The OR for T2D associated with low adiponectin was not affected by the adjustment for confounding risk factors in contrast to that of IGFBP-1 and -2, which decreased after extended adjustment (Table 2 and Supplemental Table S1). Here, ADIPOQ is linked to type 2 diabetes mellitus.